JP2004520365A - クルジパインおよび他のシステインプロテアーゼの阻害剤 - Google Patents

クルジパインおよび他のシステインプロテアーゼの阻害剤 Download PDF

Info

Publication number
JP2004520365A
JP2004520365A JP2002557927A JP2002557927A JP2004520365A JP 2004520365 A JP2004520365 A JP 2004520365A JP 2002557927 A JP2002557927 A JP 2002557927A JP 2002557927 A JP2002557927 A JP 2002557927A JP 2004520365 A JP2004520365 A JP 2004520365A
Authority
JP
Japan
Prior art keywords
alkyl
compound according
oxo
furan
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002557927A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004520365A5 (cg-RX-API-DMAC7.html
Inventor
クイベル,マーチン
ラムジー,マノー,クマー
Original Assignee
アミュラ テラピューティクス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0101204.6A external-priority patent/GB0101204D0/en
Application filed by アミュラ テラピューティクス リミテッド filed Critical アミュラ テラピューティクス リミテッド
Publication of JP2004520365A publication Critical patent/JP2004520365A/ja
Publication of JP2004520365A5 publication Critical patent/JP2004520365A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2002557927A 2001-01-17 2002-01-17 クルジパインおよび他のシステインプロテアーゼの阻害剤 Pending JP2004520365A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0101204.6A GB0101204D0 (en) 2001-01-17 2001-01-17 Biologically active compounds
US27550601P 2001-03-13 2001-03-13
PCT/GB2002/000194 WO2002057246A2 (en) 2001-01-17 2002-01-17 Inhibitors of cruzipain and other cysteine proteases

Publications (2)

Publication Number Publication Date
JP2004520365A true JP2004520365A (ja) 2004-07-08
JP2004520365A5 JP2004520365A5 (cg-RX-API-DMAC7.html) 2005-12-22

Family

ID=26245574

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002557927A Pending JP2004520365A (ja) 2001-01-17 2002-01-17 クルジパインおよび他のシステインプロテアーゼの阻害剤

Country Status (7)

Country Link
US (1) US6958358B2 (cg-RX-API-DMAC7.html)
EP (1) EP1358176A2 (cg-RX-API-DMAC7.html)
JP (1) JP2004520365A (cg-RX-API-DMAC7.html)
CA (1) CA2434068A1 (cg-RX-API-DMAC7.html)
IL (1) IL156776A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ526912A (cg-RX-API-DMAC7.html)
WO (1) WO2002057246A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051983A2 (en) * 2000-12-22 2002-07-04 Axys Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors
US20040147503A1 (en) * 2002-06-04 2004-07-29 Sheila Zipfeil Novel compounds and compositions as cathepsin inhibitors
DK1753764T3 (da) 2004-06-09 2009-02-16 Glaxo Group Ltd Pyrrolopyridin-derivater
WO2007061763A2 (en) * 2005-11-22 2007-05-31 Merck & Co., Inc. Indole orexin receptor antagonists
GB0614042D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
JP5587790B2 (ja) 2008-01-09 2014-09-10 アミュラ セラピューティクス リミティド 化合物
US20110046044A1 (en) 2009-08-24 2011-02-24 Samsung Electronics Co., Ltd. Use of a cysteine protease of Plasmodium vivax
US9409880B2 (en) 2011-01-20 2016-08-09 The Regents Of The University Of Colorado, A Body Corporate Modulators of TLR3/dsRNA complex and uses thereof
WO2026037930A1 (en) * 2024-08-16 2026-02-19 Anavo Therapeutics Bv Amide derivatives as wip1 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652574A (en) 1970-04-01 1972-03-28 Abbott Lab Certain 1 2 3 4 - tetrahydro-5h-pyrido (4 3-b)indoles and the corresponding 1 2 3 4-tetrahydro-9h-pyrido(3 4-b)indoles and derivatives thereof
DZ2285A1 (fr) 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
EP0923535A4 (en) 1996-08-28 2001-01-10 Smithkline Beecham Corp CYSTEINE PROTEASE INHIBITORS
ZA9711537B (en) 1996-12-23 1998-06-25 Athena Neurosciences Inc Eli L Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting ß-amyloid peptide release and/or its synthesis by use of such compounds.
AR013079A1 (es) * 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
CO5150165A1 (es) * 1998-11-13 2002-04-29 Smithkline Beecham Plc Inhibidores de proteasa: tipo catepsina k
GB9911417D0 (en) 1999-05-18 1999-07-14 Peptide Therapeutics Ltd Furanone derivatives as inhibitors of cathepsin s
IL155961A0 (en) 2000-11-17 2003-12-23 Medivir Uk Ltd Cysteine protease inhibitors
WO2002051983A2 (en) 2000-12-22 2002-07-04 Axys Pharmaceuticals, Inc. Novel compounds and compositions as cathepsin inhibitors

Also Published As

Publication number Publication date
US6958358B2 (en) 2005-10-25
WO2002057246A3 (en) 2002-11-21
CA2434068A1 (en) 2002-07-25
EP1358176A2 (en) 2003-11-05
US20040106805A1 (en) 2004-06-03
NZ526912A (en) 2005-02-25
IL156776A0 (en) 2004-02-08
WO2002057246A2 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
JP4608183B2 (ja) クルジパインおよび他のシステインプロテアーゼの阻害剤
AU2002219397A1 (en) Inhibitors of cruzipain and other cysteine proteases
US20060100431A1 (en) Biologically active compounds
US20100249102A1 (en) Heterotricyclic Metalloprotease Inhibitors
US6958358B2 (en) Inhibitors of cruzipain and other cysteine proteases
JP2004522738A (ja) クルジパインおよび他のシステインプロテアーゼの阻害剤としての環状2−カルボニルアミノケトン
JP2004522737A (ja) クルジパインおよび他のシステインプロテアーゼの阻害剤
CN113233996A (zh) 新型trpv1拮抗/faah抑制双靶点药物及其制备方法和应用
JP2002515428A (ja) プロテアーゼ阻害剤
JP2002537297A (ja) プロテアーゼ阻害剤
US20040127549A1 (en) Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
US20090131502A1 (en) Biologically active compounds
JP2004527575A (ja) プロテアーゼ阻害物質
CN109790107A (zh) 二苯乙烯衍生物及其制备方法
AU2002225157A1 (en) Inhibitors of cruzipain and other cysteine proteases
AU2002219399A1 (en) Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
US20050203084A1 (en) Protease inhibitors
BRPI0206501B1 (pt) An inhibitor compound of cruzipain and other cysteine ​​proteases, their uses, their pharmaceutical or veterinary composition, the process for the preparation of said composition and the method of establishing whether a cysteine ​​protease contributes to a biochemical function
KR20050019877A (ko) 생물학적으로 활성이 있는 화합물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080722

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090113